학술논문
Baseline requirements for novel agents being considered for phase II/III brain cancer efficacy trials: conclusions from the Adult Brain Tumor Consortium’s first workshop on CNS drug delivery
Document Type
article
Author
Source
Neuro-Oncology. 22(10)
Subject
Language